ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord ...

Onward Medical announced today that a neurosurgeon performed the first human implant of its investigational ARC-IM lumbar ...

EINDHOVEN, the Netherlands, March 26, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore ...

(RTTNews) - Onward Medical NV (ONWDB.XD), on Wednesday announced the first human implant of its investigational ARC-IM Lumbar Lead on March 17, 2025. This milestone procedure, performed by Dr.

ONWARD Medical is a medical technology company creating therapies to restore movement, function, and independence in people with SCI and other movement disabilities. Building on more than a decade ...

The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead family to be used in a clinical feasibility study The Company is building a portfolio of purpose-designed leads to optimize delivery of ...

EINDHOVEN, the Netherlands, March 26, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore ...

The webcast will be held on April 1, 2025, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver, who will discuss highlights from 2024 and provide a business update. To join the webcast ...

EINDHOVEN, the Netherlands, March 19, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore ...